Yongtai Bio-product, a new open-source shareholding company, was recognized by CDE for breakthrough therapy. On December 11th, official website, China National Medical Products Administration Drug Evaluation Center (CDE), recently announced that the anti-CD19 single-chain antibody chimeric antigen receptor T cell injection (CAR-T-19 cell injection for short) developed by Yongtai Bio-B (06978.HK) was successfully included in the list of breakthrough therapy varieties by CDE, and the indication was recurrence under 25 years old/.In response to the Democratic Progressive Party authorities' deletion of the military academy curriculum on the island, the Taiwan Affairs Office spokeswoman Zhu Fenglian said: The Democratic Progressive Party authorities, out of the "Taiwan independence" nature, made great efforts to "de-China". Previously, they introduced the so-called "educational reform" policy and "Taiwan independence" curriculum, and this time they deleted the military academy curriculum on the island, so that military academy students could not see the history of the Anti-Japanese War and learn the wisdom of ancient China people. They tried to cut off the historical and cultural ties between the two sides of the Taiwan Straits in various ways, so as to deceive the people of Taiwan Province and deceive the young people of Taiwan Province into going to the battlefield for "Taiwan independence" and acting as cannon fodder for "Taiwan independence", which requires high vigilance. Facts have proved, and will continue to prove, that any "de-China" act can not separate the historical ties between the two sides of the strait and the blood ties between compatriots on both sides of the strait, let alone change the fact that Taiwan Province is a part of China. The perverse actions of the Democratic Progressive Party authorities are bound to be resolutely opposed by more and more Taiwan Province compatriots.Beijing Stock Option Pioneer Venture Capital Fund was registered and established with a capital contribution of 100 million yuan. According to Tianyancha App, recently, the Stock Option Pioneer Venture Capital Fund (Limited Partnership) was established. The executive partner is Beijing Zhongguancun Capital Fund Management Co., Ltd., with a capital contribution of 100 million yuan. Its business scope is venture capital, and private equity funds are engaged in equity investment, investment management, asset management and other activities. According to the partner information, the fund is jointly funded by Beiyin Wealth Management Co., Ltd., Beijing Zhongguancun Capital Fund Management Co., Ltd. and Beijing Harmony Jiarui Investment Management Co., Ltd.
In response to MAC's refusal to lift the ban on group tours to mainland China, Democratic Progressive Party authorities deliberately confuse the audience and make excuses for refusing to lift the ban on group tours to mainland China, further exposing their confrontational nature of "independence", showing that they have no intention to promote cross-strait personnel exchanges and benefit the tourism industry and grassroots people in Taiwan Province, and arousing stronger dissatisfaction and opposition from the industry on the island and Taiwan Province compatriots. Adhering to the concept of "one family on both sides of the strait", we always respect, care for and benefit Taiwan Province compatriots, and always support the normalization of cross-strait personnel exchanges and cross-strait exchanges in various fields, including tourism. We warmly welcome Taiwan Province compatriots to visit the mainland for sightseeing, visiting relatives and friends, visiting and communicating, and studying and working.Jinling Pharmaceutical Co., Ltd.: Magnesium sulfate injection has obtained the drug registration certificate. Jinling Pharmaceutical Co., Ltd. announced that Nanjing Jinling Pharmaceutical Factory, a subsidiary of the company, recently received the "Drug Registration Certificate" for magnesium sulfate injection issued by National Medical Products Administration. Magnesium sulfate injection can be used for the treatment of pregnancy-induced hypertension, eclampsia and preeclampsia, and plays an important role in the prevention and treatment of many diseases. The drug has been recommended by related guides in China, the United States and Canada. This drug registration is conducive to the company's future market expansion and sales, but the production and sales of drugs may be affected by changes in policies and market environment, which is uncertain.China made more than half of the imported cars registered in South Korea in November. According to a data released by CARISYOU, a Korean automobile data research institution, the proportion of Chinese-made cars registered in South Korea in November was 54.3%, setting a record this year. The data shows that there were 659 newly registered imported cars in November, of which 358 were made in China, accounting for 54.3%, setting a record for the highest proportion in a single month this year. By brand, BYD increased by 21.7% year-on-year to 140 vehicles, ranking first among all imported car brands. Brands such as Geely (No.3), Xinyuan (No.4), Haig School Bus (No.8) and Dongfeng Xiaokang (No.10) are also among the top ten. The number and proportion of Chinese-made cars registered in Hanxin increased year by year, with only 296 (6.2%) in 2020, 569 (9.9%) in 2021, 2276 (29%) in 2022 and 4215 (47.5%) in 2023.
The CSI A500ETF paid dividends for the first time. On December 11th, ICBC Credit Suisse announced the dividend, becoming the first CSI A500ETF product to announce the dividend. The dividend plan is to allocate 0.066 yuan for every 10 fund shares, the base date of income distribution is November 29, and the net value of fund shares on the base date is 1.0078 yuan. In addition, ICBC Credit Suisse CSI A500ETF's dividend registration date is December 13th, and the cash dividend payment date is December 18th.Hong kong stocks minimally invasive robots rose more than 13%. The company completed the placement of a total of 34.7 million shares, and the net proceeds from the placement were about HK$ 266 million.The three departments issued the tax policy on the transformation of operating cultural institutions into enterprises in the cultural system reform, and the Ministry of Finance, the State Administration of Taxation and the Central Propaganda Department issued the Announcement on the Tax Policy on the Transformation of Operating Cultural Institutions into Enterprises in the Cultural System Reform, which mentioned that operating cultural institutions can enjoy the following transitional tax preferential policies: if operating cultural institutions are transformed into enterprises before December 31, 2022, they will be exempted from enterprise income tax from the date of registration of transformation to December 31, 2027. If a cultural unit funded by the financial department is transformed into an enterprise before December 31, 2022, its self-use property will be exempted from property tax from the date of registration of transformation to December 31, 2027.
Strategy guide 12-14
Strategy guide
12-14